Mesothelioma - Lung cancer apoptosis enhanced by adenylate cyclase toxin
Lung cancer apoptosis enhanced by adenylate cyclase toxin
Therapeutics Daily (subscription) (press release), PA - Apr 26, 2006... A malignant mesothelioma cell line (P31) and a small-cell lung cancer cell line (U 1690) were exposed to increasing concentrations of cisplatin and AC toxin ...
Alfacell Provides Update on ONCONASE Phase IIIb Confirmatory ...
PharmaLive.com (press release), PA - Apr 28, 2006... trial evaluating ONCONASE(R) (ranpirnase), the Company's lead investigational drug candidate, as a treatment for unresectable malignant mesothelioma (UMM). ...
American Journal of Respiratory and Critical Care Medicine Vol 173 ...
AJRCCM (subscription), NY - Mar 28, 2006... In a murine model of malignant mesothelioma, dendritic cells pulsed with tumor lysate, and administered before tumor implantation, demonstrated protective ...
Alfacell achieves full patient enrollment for Onconase phase IIIb ...
Therapeutics Daily (subscription) (press release), PA - Mar 28, 2006... trial evaluating Onconase (ranpirnase), the company's lead investigational drug candidate, as a treatment for unresectable malignant mesothelioma (UMM). ...
